ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Top Brokers

More Brokers

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
FTSE 100
8,173.02
0.64%
Dow Jones
42,544.22
-0.07%
Gold vs US Dollar
2,625.695
0.06%
Brent Oil
73.855
0.00%
Bitcoin
94,832.29
0.47%
Pepperstone
Advertisement
Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ

  6. Avalo Therapeutics Inc (AVTX) Share Price

AVTX Avalo Therapeutics Inc

7.43
-0.37 (-4.74%)
01 Jan 2025 - Closed
Delayed by 15 minutes
 Name  Symbol  Market  Type  ISIN  Description 
 Avalo Therapeutics Inc NASDAQ:AVTX NASDAQ Common Stock  
     Change  % Chg  Cur  Bid  Offer  High  Low  Open  Volume  Chg Time
Upgrade Icon
 		 RN  NRN 
   -0.37 -4.74 7.43 6.80 12.37 8.14 7.3409 7.8 44,833 05:00:07   
 Sector  Turnover  Profit  EPS - Basic  PE ratio  Mkt Cap 
 Pharmaceutical Preparations 1.92M -31.54M -3.0348 -0.97 81.07M
 Type  Size  Price  Time  Units 
 13 3,120 7.43 21:00:00 USD
 
Pre-Market and After-Hours
Recent News
DateTimeSource
HeadlineMore AVTX News
31/12/202421:13EDGAR2Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
05/12/202412:03EDGAR2Form 8-K - Current report
14/11/202417:05EDGAR2Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
12/11/202412:30EDGAR2Form 8-K - Current report
12/11/202412:00GLOBEAvalo Therapeutics Receives $69.4 Million in Proceeds from the Full Exercise of Private Placement Warrants
11/11/202412:00GLOBEAvalo Therapeutics to Present at Upcoming Investor Conferences
07/11/202422:00EDGAR2Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Period
Draw mode
Data Downloads for AVTX

Export historical price information open, high, low, close, volume (OHLCV) to Excel

Intraday price data (2 weeks, 1 minute bars)


Loading Follow Feed...

Latest Avalo Therapeutics Inc Articles

Go Ad-Free

Subscribe to Ad free and enjoy an ad-free experience

No Ads

Try Now

Keep the Ads